Ctrl

K

Racepinephrine

Class
Sympathomimetics
Subclass
Catecholamines
Generic name
Racepinephrine
Brand names
Asthmanefrin®
Common formulations
Solution
Dosage and administration
Adults patients
Symptomatic relief of asthma • Mild, intermittent symptoms
•
Maintenance: 1-3 application(s) INH q3h (13.5 mg per 0.5 mL)
•
Maximum: 12 application(s) per day
Add 0.5 mL (contents of one vial) of solution to nebulizer.
Indications for use
Labeled indications
Adults
•
Symptomatic relief of asthma (mild, intermittent symptoms)
Children
•
Symptomatic relief of asthma (intermittent, mild symptoms)
Pregnancy and breastfeeding
Pregnancy
All trimesters
•
Insufficient evidence. The manufacturer makes no recommendation regarding use during pregnancy.
•
There is no data on use of racepinephrine during pregnancy.
•
Racepinephrine is a racemic mixture of both the D- and L-isomers of epinephrine; epinephrine contains only the L-isomer.
•
Epinephrine freely crosses the placenta and may be teratogenic in some species, but does not appear to be teratogenic in humans.
•
In the Collaborative Perinatal Project, there was a statistically significant association between the use of epinephrine during pregnancy and major and minor malformations, including inguinal hernia.
Breastfeeding
Little information available on breastfeeding safety.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Create free account

Sign up for free to access the full drug resource